Soligenix Inc  

(Public, OTCBB:SNGX)   Watch this stock  
Find more results for OTC:SNGX
2.15
-0.02 (-0.97%)
Delayed:   3:01PM EST
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 2.07 - 2.30
52 week 0.91 - 2.49
Open 2.17
Vol / Avg. 418,055.00/220,972.00
Mkt cap 51.46M
P/E     -
Div/yield     -
EPS -0.38
Shares 23.94M
Beta 2.17
Inst. own 18%
Mar 10, 2015
Soligenix Inc at ROTH Conference - 4:00PM EDT - Add to calendar
Feb 10, 2015
Soligenix Inc at Biotechnology Industry Organization CEO & Investor Conference
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -156.03% -311.99%
Operating margin -184.43% -221.97%
EBITD margin - -214.83%
Return on average assets -280.96% -155.11%
Return on average equity - -1129.41%
Employees 17 -
CDP Score - -

Address

29 Emmons Dr Ste C10
PRINCETON, NJ 08540-5919
United States - Map
+1-609-5388200 (Phone)
+1-609-4526467 (Fax)

Website links

Description

Soligenix, Inc. (Soligenix) is a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics. The BioTherapeutics segment of the Company is developing formulations of oral beclomethasone, while The Vaccines/BioDefense segment of the Company is involved in active development programs for RiVax, the ricin toxin vaccine, VeloThrax, the anthrax vaccine, OrbeShield, the GI acute radiation syndrome (GI ARS) therapeutic and SGX943, the melioidosis therapeutic.

Officers and directors

Christopher J. Schaber Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 47
Joseph M. Warusz CPA Acting Chief Financial Officer, Vice President - Finance, Corporate Secretary
Age: 57
Oreola Donini Ph.D. Senior Vice President, Chief Scientific Officer
Richard Straube M.D. Senior Vice President and Chief Medical Officer
Age: 62
Rasappa Arumugham Ph.D. Vice President - Biopharmaceutical Development
Marco Maria Brughera Director
Age: 59
Keith L. Brownlie CPA Independent Director
Age: 61
Anthony Gregg Lapointe C.P.A. Independent Director
Age: 55
Robert Joseph Rubin M.D. Independent Director
Age: 68
Jerome B Zeldis M.D., Ph.D. Independent Director
Age: 64